AKCEA THERAPEUTICS
Dead / Cancelled — Cancelled — Section 8 (as of 21 Mar 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86480621
- Registration number
- 5561326
- Mark type
- Stylized text
- Filed
- 15 Dec 2014
- Published for opposition
- 09 Jun 2015
- Registered
- 11 Sept 2018
- Attorney of record
- Brian Focarino
Goods and services
- Class 042 — Scientific and technological services: Drug discovery services; Laboratory research services relating to pharmaceuticals; Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields
Owner
- AKCEA THERAPEUTICS, INC., Cambridge, MA, US
- IONIS PHARMACEUTICALS, INC., CARLSBAD, CA, US
- IONIS PHARMACEUTICALS, INC., CARLSBAD, CA, US
- Isis Pharmaceuticals, Inc., Carlsbad, CA, US
- Isis Pharmaceuticals, Inc., Carlsbad, CA, US
Prosecution history
- 21 Mar 2025 — CANCELLED SEC. 8 (6-YR)
- 25 Sept 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 25 Sept 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Sept 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Sept 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Sept 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Sept 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Sept 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 29 Jul 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 11 Sept 2018 — REGISTERED-PRINCIPAL REGISTER
- 07 Aug 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Aug 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Jul 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Jul 2018 — USE AMENDMENT FILED
- 27 Jul 2018 — TEAS STATEMENT OF USE RECEIVED